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TAKE HOME MESSAGE: 
CALIPER-derived parameters such as pulmonary vessel volume, are more accurate 
prognostically than visual CT scores.  
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ABSTRACT 
Computer-based CT analysis can provide objective quantitation of disease in 
idiopathic pulmonary fibrosis (IPF). A computer algorithm, CALIPER, was compared 
with conventional CT and pulmonary function measures of disease severity for 
mortality prediction.  
 
283 consecutive patients with an IPF multidisciplinary diagnosis had variables 
evaluated against mortality: visual and CALIPER features (total interstitial lung 
disease extent, honeycombing, reticular pattern, ground glass opacities, pulmonary 
vessel volume, emphysema, traction bronchiectasis and consolidation) and 
pulmonary function tests (FEV1, FVC, DLco, Kco and a composite physiologic index). 
A combination of mortality predictors was compared with the gender, age, 
physiology model. 
 
On univariate analyses, all visual and CALIPER-derived interstitial features and 
functional indices were predictive of mortality to a 0·01 level of significance. On 
multivariate analysis, visual CT parameters were discarded. Independent predictors 
of mortality were: composite physiologic index (HR=1·05, CI=1·02-1·07, p<0·001) and 
two CALIPER parameters: pulmonary vessel volume (HR=1·23, CI=1·08-1·40, p=0·001) 
and honeycombing (HR=1·18, CI=1·06-1·32, p=0·002). A three group staging system 
derived from this model was powerfully predictive of mortality (HR=2.23, CI=1.85-
2.69, p<0.0001). 
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CALIPER-derived parameters, in particular the pulmonary vessel volume, are more 
accurate prognostically than traditional visual CT scores. Quantitative tools such as 
CALIPER have the potential to improve staging systems in IPF.  
 
 
KEY WORDS: quantitative CT of ILD, pulmonary vessels, idiopathic pulmonary 
fibrosis, CALIPER  
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INTRODUCTION: 
Accurate prognostication is central to the management of patients with idiopathic 
pulmonary fibrosis (IPF). In addition to informing a patient of their probable life 
expectancy,
1
 accurate prediction of a patients likely clinical course allows institution 
of appropriate management which today may include anti-fibrotic medication, 
referral for transplantation,
2
 or palliative care pathways. 
 
However prognostication in IPF is fraught with difficulties. An array of prognostic 
indicators have been used over the years, but have met with varying degrees of 
success in IPF. Pulmonary function tests such as DLco are perhaps the most sensitive 
markers of disease severity but are associated with a measurement variation of 
between 10-15% per test. 
3
 Visual CT evaluation has to contend with interobserver 
variation. 
4, 5
 Composite indices have also been proposed but are yet to be fully 
validated. 
6
 As a result, new tools that may be more accurate in predicting a patient’s 
prognosis are required. A recent recommendation from the Fleischner society,
7
 has 
emphasized computer-based quantitative CT analysis as a potential outcome 
measure in IPF. 
 
Establishing whether a quantitative tool has the ability to substitute as a marker of 
disease outcome requires evaluation of the tool against other markers of baseline 
disease severity. A sophisticated quantitative CT algorithm (CALIPER) has been 
shown to have better correlations with pulmonary function tests than semi-
quantitative visual CT evaluation. 
8
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The aims of our study were to compare CALIPER, visual CT scoring and pulmonary 
function tests (PFTs) against survival in IPF. Optimal stratification was explored using 
CALIPER variables, visual variables, PFTs and the GAP score. 
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METHODS 
A retrospective analysis of an interstitial lung disease database identified all 
consecutive, newly attending patients receiving a multidisciplinary team diagnosis of 
IPF according to published guidelines,
9
 over a four and a half year period (January 
2007 to July 2011). Patients with a departmental, non-contrast, supine, volumetric 
CT were included in the study cohort (as per CONSORT in Figure 1). CT, 
echocardiography and pulmonary function test protocols are included in the online 
appendix as are details of CALIPER CT evaluation. The DICOM images for the CT scans 
were transferred to the Biomedical Imaging Resource (BIR), Mayo Clinic, Rochester, 
USA for blinded CALIPER processing. Approval for this study of clinically indicated CT 
and pulmonary function data was obtained from the Institutional Ethics Committee 
of the Royal Brompton Hospital and the Institutional Review Board of the Mayo 
Clinic. 
 
Visual CT evaluation: 
Each CT scan was evaluated independently by two radiologists (AN, SLW) with 5 and 
7 years thoracic imaging experience respectively, blinded to all clinical information. 
An initial training dataset of 15 non-study cases was used to help to identify pre-
existing biases. The scores of the test cases were reviewed and the most widely 
discrepant results discussed with a third radiologist (JJ).  
 
CTs were scored on a lobar basis using a continuous scale. The total interstitial lung 
disease (ILD) extent was initially estimated to the nearest 5%, then sub-classified into 
four patterns: reticular pattern, ground glass opacification, honeycombing and 
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consolidation, using definitions from the Fleischner Society glossary of terms for 
thoracic imaging. 
10
 To derive a lobar percentage for each parenchymal pattern, the 
total lobar ILD extent was multiplied by individual lobar parenchymal pattern extents 
and divided by 100. Furthermore, the percentage (to the nearest 5%) of each lobe 
that contained mosaicism (decreased attenuation component) or emphysema was 
recorded. The individual lobar percentages of each parenchymal pattern were 
summed for each radiologist and divided by six to create an averaged lobar score per 
pattern, per scorer per case.  
 
Traction bronchiectasis, as defined in the Fleischner society glossary of terms,
10
 was 
assigned with a categorical “severity” score that took into account the average 
degree of airway dilatation within areas of fibrosis as well as the extent of dilatation 
throughout the lobe and was given a gestalt score of: none=0, mild=1, moderate=2, 
severe=3. An index of pulmonary hypertension (main pulmonary artery:ascending 
aorta ratio) was assessed by a single scorer using electronic caliper diameter 
measurements of the ascending aorta and pulmonary artery diameters at the level 
of the pulmonary artery bifurcation. 
11
 Consensus formulation for visual scores is 
outlined in the online appendix. 
 
CALIPER CT evaluation: 
Data processing: Initial data processing steps involved extraction of the lung from 
the surrounding thoracic structures and segmentation into upper, middle and lower 
zones. Lung segmentation was performed with an adaptive density-based 
morphological approach,
12
 whilst airway segmentation involved iterative three-
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dimensional region growing, density thresholding (thresholds including -950HU and -
960HU) and connected components analysis. Segmentation of pulmonary vessels, 
prior to their extraction, was achieved using an optimized multi-scale tubular 
structure enhancement filter based on the eigenvalues of the Hessian matrix. The 
filters calculated the 2nd-order derivatives that occurred in the regions that 
surrounded each pulmonary voxel. The eigenvalues of the Hessian matrix that were 
constructed from the derivatives were then analyzed, and from these values, it was 
possible to determine the likelihood that an underlying voxel was connected to a 
dense tubular structure and therefore represented a vessel.
13, 14
 The pulmonary 
vessel volume (PVV) score quantified the volumes of pulmonary arteries and veins 
excluding vessels at the lung hilum as a percentage of lung volume (Figure 2).  
 
Parenchymal tissue type classification was applied to 15x15x15 voxel volume units 
using texture analysis, computer vision-based image understanding of volumetric 
histogram signature mapping features and 3D morphology.
13
 The CALIPER tool was 
trained by sub-specialty thoracic radiologist consensus assessment of pathologically 
confirmed datasets.
13, 15
 
 
Pattern evaluation: CALIPER evaluation of CT data involved algorithmic identification 
and volumetric quantification of every voxel volume unit into one of eight 
radiological parenchymal features: normal lung, three grades of decreased lung 
attenuation (grade 1=mild, 2=moderate 3=marked), ground glass opacification, 
reticular pattern, honeycombing and the pulmonary vessels (Figure 2). Volumes for 
all eight parenchymal features were converted into a percentage using the total lung 
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volume also measured by CALIPER. Total ILD extent represented the sum of ground 
glass, reticular and honeycomb percentages. The sum of grade 2 and 3 decreased 
lung attenuation represented emphysema. 
8
 
 
Statistical analysis: 
Data are given as medians, means with standard deviations, or numbers of patients 
with percentages where appropriate. Interobserver variation for visual scores was 
assessed using the single determination standard deviation. Linear regression 
analyses were performed to explore relationships between the PVV and both 
CALIPER ILD extent and RVSP. Univariate and multivariate Cox regression analyses 
were used to investigate relationships within and between the three data sets: 
CALIPER CT evaluation, visual CT evaluation and pulmonary function tests. In all 
study analyses, a p-value of <0.01 was considered significant. 
 
The hazard ratios for those parameters that were independent predictors of 
mortality on multivariate Cox regression analysis were used to generate a formula 
that represented an estimate of mortality for each patient. The hazard ratios for 
CALIPER parameters alone that were independent predictors of mortality on 
multivariate Cox regression analysis were also used to generate a separate formula 
that represented an estimate of mortality for each patient.  
 
The mortality estimates derived from the hazard ratio scores were converted into 
categorical scores and compared to mortality estimates derived from the Gender, 
Age, Physiology (GAP) index staging system,
16
 using univariate and bivariate Cox 
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regression analyses, Kaplan Meier survival plots and the log-rank test. Robustness of 
results were confirmed using bootstrapping and resampling of the dataset up to 
1000 times. Goodness of fit of the survival models was calculated using Harrells 
concordance index. Assumptions of linearity and proportional hazards were tested 
by visual inspection of Martingale residuals and scaled Schoenfeld residuals. 
Statistical analyses were performed with STATA (version 12, StatCorp, College 
Station, TX, USA). 
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RESULTS 
Demographic data 
The study population consisted of 283 consecutive patients with a multidisciplinary 
diagnosis of IPF. The median age at presentation was 67 years, the mean follow up 
time was 30 months (±21·5 months) and 210 patients (74%) died during the study 
period. Data on vital status was completed on 98.6% of cases with 4 patients 
censored (1.4%). Demographic data and average visual score, CALIPER score and 
pulmonary function test data are provided in Table 1. Interobserver variation values 
for the visual scores are provided in the supplementary appendix.  
 
Mortality Analyses 
All visual and CALIPER-derived interstitial features were predictive of mortality. The 
CALIPER-derived PVV (shown in Figure 2) was highly significant on univariate analysis 
as were all pulmonary function tests, the right ventricular systolic pressure (RVSP) 
and the GAP score (Table 2). When RVSP and CALIPER ILD extent were each placed 
alongside PVV in a bivariate mortality analysis, only PVV remained independently 
predictive of mortality. On linear regression analysis, major co-linearity was 
demonstrated between PVV and CALIPER ILD extent (R
2
=0.76, p<0.0001). 
8
 A lesser 
degree of co-linearity was demonstrated between PVV and RVSP (R
2
=0.20, 
p<0.0001).  
 
On stepwise proportional hazards analysis, the independent CALIPER-derived 
predictors of mortality were: honeycombing and the PVV (Table 3). On multivariate 
analysis of pulmonary function indices, the CPI was the strongest predictor of 
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mortality. A multivariate Cox regression analysis combining CALIPER scores, visual 
scores, pulmonary function tests and the GAP score demonstrated the CPI (which 
has been previously validated by CALIPER 
8
) to be the variable that best quantified 
the severity of ILD. The two remaining CT variables independently predictive of 
mortality were derived by CALIPER: honeycombing and PVV. No visually scored CT 
parameters were independently associated with mortality (Table 3). When the GAP 
score was substituted for the CPI in the final multivariate model, though it was 
retained as an independent predictor of mortality, it was not as strong as the CPI in 
the model (Table 3). 
 
Comparisons of composite variables  
A further mortality evaluation compared the GAP index staging system 
16
 to two 
mortality estimates derived from the hazard ratios of two multivariate models. One 
formula was derived from the hazard ratios of the final three independent predictors 
of mortality (CALIPER-CPI score) as follows: 
 
CALIPER-CPI score = (CALIPER PVV x 23·0904) + (CALIPER honeycombing x 18·3795) + 
(CPI x 4·5065) 
 
The second formula was derived from the hazard ratios of the two variables that on 
multivariate analysis of CALIPER scores were independent predictors of mortality 
(CALIPER-only score): 
 
CALIPER-only score = (CALIPER PVV x 52·9004) + (CALIPER honeycombing x 12·0524)  
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Both the CALIPER-CPI and CALIPER-only scores were converted into categorical 
scores by aligning the individual scores in ascending numerical order and dividing the 
respective cohorts into three equally sized groups (n=83). Univariate Cox regression 
analyses demonstrated that the CALIPER-CPI and CALIPER-only categories were not 
only of similar prognostic strength to the GAP index staging system, but 
demonstrated improved goodness of fit as models (Table 4).  
 
On bivariate Cox regression analysis, the GAP index staging system did not retain 
significance against the CALIPER-CPI categories, a result confirmed with 
bootstrapping of 1000 samples (Table 4). The GAP index staging system was also 
shown to be a weaker predictor of mortality than the CALIPER-only categories, again 
confirmed with bootstrapping of 1000 samples. Kaplan Meier survival curves 
demonstrated similar separation of the groups using the CALIPER-CPI and CALIPER-
only categories when compared to the GAP index staging system (log-rank test 
p<0.0001 for the GAP index staging system, CALIPER-CPI and CALIPER-only 
categories) (Figure 3).  
 
When the CALIPER-CPI and CALIPER-only scores were adjusted such that patient 
numbers in each of the groups were identical to the patient numbers in the GAP 
staging system groups, the relationships on univariate analysis and bivariate analysis 
with bootstrapping did not change. Goodness of fit of the two models was similar to 
that of the GAP index staging system (Harrells C index=0.66 for the CALIPER-CPI 
score and 0.65 for the CALIPER-only score). Kaplan Meier survival curves again 
demonstrated similar separation of the groups using the new adjusted CALIPER-CPI 
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and CALIPER-only categories when compared to the GAP index staging system (log-
rank test p<0.0001 for the adjusted CALIPER-CPI and CALIPER-only categories) 
(Figure 3). 
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DISCUSSION 
Our study has demonstrated that computer-derived quantitative CT parameters are 
better predictors of mortality in IPF than visually scored parameters. When patients 
are stratified on the basis of CALIPER variables and the CPI, mortality prediction is 
improved when compared to stratification using the GAP index staging system. 
Central to the strength of mortality prediction using CALIPER was a single variable, 
the pulmonary vessel volume (PVV). The PVV is a novel CALIPER variable with no 
visually scored equivalent. Accordingly, the PVV may represent a new parameter in 
the evaluation of patients with IPF. 
 
DLco has long been considered the parameter that best reflects disease severity at 
baseline in IPF,
17
 but is handicapped by measurement noise ranging between 5-15%. 
3, 18
 Consequently, interest is increasing in exploring other potential markers of 
disease severity or worsening in IPF such as peripheral blood
19
 and imaging 
biomarkers.
7
 Given the rapid technological advances of computer based quantitative 
CT,
13
 an exploration of their potential accuracy in assessing IPF is timely. 
 
In the current study, on univariate analysis, visually scored reticular pattern, 
honeycombing and traction bronchiectasis were predictive of mortality confirming 
the conclusions of a previous study which evaluated the prognostic significance of 
the same patterns in patients with a histopathologically proven UIP pattern.
20
  
 
The final combined visual, CALIPER and CPI multivariate model identified three 
independent predictors of survival. One of these was the CPI, and the finding 
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confirms previous reports highlighting the strength of signal of the CPI in predicting 
outcome in fibrosing lung disease.
21, 22
 Similarly the prognostic signal associated with 
honeycombing when scored by CALIPER confirms results from visual scoring of the 
same pattern in IPF. 
23
 
 
The co-linearity demonstrated between PVV and CALIPER ILD extent and between 
PVV and RVSP suggests that the PVV might represent a variable that simultaneously 
captures disease within the interstitial and vascular compartments. It is noteworthy 
that CALIPER software was originally designed to segment out and discard vascular 
structures (rather than quantify them) and in so doing optimize the classification of 
parenchymal patterns. In cases with more severe fibrosis on CT, vessel segmentation 
inevitably captures a minor degree of peripheral reticular pattern (Figure 2). There is 
the potential to refine vessel delineation by CALIPER, or a similar quantitative tool, 
and thus improve the prognostic signal of this new CT parameter.  
 
The basis of the signal provided by pulmonary vessel volume is obscure. PVV has not 
previously been studied as a prognostic marker in IPF or considered as a prognostic 
indicator independent of pulmonary hypertension. Recent IPF studies assessing the 
complex interactions between angiogenic and angiostatic mediators in disease 
pathogenesis, 
24
 have primarily considered the vasculature through the prism of 
overt pulmonary hypertension.
25
  
 
Blood perfusion in areas of fibrosis has been shown to be reduced,
26
 but conversely 
increased in spared lung adjacent to areas of fibrosis.
27, 28
 It follows that the strong 
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correlations between ILD extent and vessels may reflect regional, subclinically 
elevated local pulmonary arterial pressures within mildly fibrotic lung, or capillary 
bed destruction in more advanced disease, which may produce a preferential 
diversion of blood flow to relatively spared or non-fibrotic lung. The vascular 
capacitance of spared lung (the upper and middle lobes in patients with IPF, a 
predominantly basal disease) may result in an increase in vessel volume in more 
advanced disease. The identification of greater numbers of vessels, of a size that 
could be detected by CALIPER, could therefore act as a surrogate marker for the 
extent and severity of parenchymal disease in IPF.  
 
Another possible explanation for the relationship between PVV and ILD extent 
relates to the increased negative intra-thoracic pressure that non-compliant fibrotic 
lungs need to generate during inspiration. The transmission of high negative 
pressures through the pleural space into the parenchyma could in turn be exerted on 
the vasculature, resulting in dilatation throughout the lung and an increase in 
capacitance. A third possible mechanism relates to pleuroparenchymal and/or 
bronchial-pulmonary artery anastomoses described histopathologically in patients 
with fibrosing lung disease.
29
 While the clinical importance of shunting within the 
lungs is yet to be established,
30
 the development of shunts could theoretically 
increase the PVV as fibrosis progresses. 
 
The evaluation of CALIPER in our previous study highlighted the close correlations 
between parenchymal patterns scored using an automated computer system and 
pulmonary function indices. 
8
 The results suggested that a tool such as CALIPER, 
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when used alone, could be a viable alternative to pulmonary function testing in 
predicting outcome in IPF. Our mortality analyses have also underlined the 
importance of integrating structural and functional parameters for prognostication 
in IPF. The CPI when combined with CALIPER variables produced a stronger model 
with which to predict mortality than was achieved by CALIPER or functional indices 
alone. 
 
The GAP score is a multidimensional continuous score that aims to predict mortality 
in IPF by utilizing commonly measured clinical and physiological variables.
16
 The GAP 
score was shown to be a strong univariate predictor of mortality in our study, and 
was enhanced when combined with CALIPER variables in a multivariate model. 
However, the model was not as powerful as the combination of CALIPER variables 
with CPI. The findings highlight a relative weakness of the GAP score consequent 
upon its relatively coarse nine-point gradation, whereas the continuous nature of 
the CPI allows the CPI to be more discriminatory. 
 
The GAP staging system represents a categorical version of the GAP score.
16
 A 
consequence of stratification according to the GAP staging system is that only 50% of 
patients in the current study constituted GAP groups 1 and 3 (patients with mild and 
severe disease respectively). Yet it is precisely such patients that require 
identification in IPF cohorts. Those identified as likely to have limited disease can be 
monitored using a watch and wait policy, whilst those with more severe disease 
might be referred earlier for transplantation.
2
 When stratification with the CALIPER-
CPI categories was performed, despite the arbitrary division of the patients into 
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evenly sized groups, prognostication and goodness of fit was improved when 
compared to the categorical GAP staging system.  
 
In conclusion we have shown that quantitative computer-derived CT variables in IPF 
are superior predictors of mortality than any visually scored CT parameter. 
Stratification using CALIPER variables and CPI provides a stronger mortality signal 
than stratification using the GAP index. But one CALIPER variable in particular, the 
pulmonary vessel volume, has the strongest link with mortality and could be a new 
index in the evaluation of IPF. 
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Variable (n = 283 unless stated) 
Units are percentage unless stated 
 Value 
 
Median Age (years)        67 
Male/female    219/64  
Never smokers    97 (34%) 
Ex-smokers  178 (63%) 
Current smokers       8 (3%) 
Lung biopsy     60 (21%) 
Mean follow up time (months)  30·0 ± 21·5 
FEV1 % predicted (n=257)  70·8 ± 19·1 
FVC  % predicted (n=257)  68·8 ± 20·5 
DLco  % predicted (n=254)  36·1 ± 12·9 
Kco  % predicted (n=254)  69·0 ± 19·2 
TLC % predicted (n=241)  63·7 ± 15·9 
CPI (n=249)  55·1 ± 11·7 
CALIPER total ILD extent   26·5 ± 18·1 
  CALIPER ground glass opacity   17·0 ± 14·7 
  CALIPER reticular pattern     8·5 ± 6·0 
  CALIPER honeycombing     1·0 ± 1·7 
CALIPER PVV     5·1 ± 1·7 
CALIPER Grade 1 decreased attenuation   20·8 ± 20·7 
CALIPER Grade 2 decreased attenuation    0·8 ± 2·6 
CALIPER Grade 3 decreased attenuation     0·5 ± 2·8 
Visual ILD extent  43·1 ± 17·8 
  Visual ground glass opacity   10·4 ± 11·4 
  Visual reticular pattern   21·7 ± 10·9 
  Visual honeycombing     9·8 ± 12·6 
  Visual consolidation    1·1 ± 3·3 
Visual emphysema     4·7 ± 10·9 
Visual mosaic attenuation     0·8 ± 2·1 
Visual TxBx severity (maximum score 18)    7·0 ± 3·3 
Main pulmonary artery diameter (mm)  30·3 ± 4·8 
Ascending aorta diameter (mm)  34·8 ± 4·2 
Echocardiography RVSP (mmHg) (n=150)  45·1 ± 16·8 
 
Table 1. Patient demographics and mean and standard deviations of pulmonary function 
tests, CALIPER and visually scored CT parameters and echocardiography data. CPI=composite 
physiologic index, CT=computed tomography, FEV1=forced expiratory volume in one 
second, FVC=forced vital capacity, DLco=diffusing capacity for carbon monoxide, 
Kco=Carbon monoxide transfer coefficient, TLC=total lung capacity, RV/TLC=residual volume 
expressed as a percent of total lung capacity, ILD=interstitial lung disease, PVV=pulmonary 
vessel volume, TxBx=traction bronchiectasis, RVSP=right ventricular systolic pressure.  
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 Patient 
Number 
Hazard 
ratio 
P Value 95.0% Confidence 
Interval 
Lower Upper 
CALIPER score      
  Total ILD extent 283 1·03 <0·0001 1·03 1·04 
  Ground glass opacity 283 1·03 <0·0001 1·02 1·04 
  Reticular pattern 283 1·10 <0·0001 1·07 1·12 
  Honeycombing 283 1·11   0·006 1·03 1·20 
  Grade 1 DA 283 0·97 <0·0001 0·97 0·98 
  Grade 2 DA 283    NS   
  Grade 3 DA 283    NS   
  Normal lung 283    NS   
  PVV 283 1·52 <0·0001 1·40 1·65 
VISUAL score      
  ILD extent 283 1·03 <0·0001 1·02 1·04 
  Ground glass opacity 283 1·01   0·03 1·00 1·03 
  Reticular pattern 283 1·02   0·002 1·01 1·03 
  Honeycombing 283 1·03 <0·0001 1·03 1·07 
  Consolidation 283 1·08 <0·0001 1·04 1·12 
  Total emphysema 283    NS   
  Mosaicism 283    NS   
  TxBx severity 283 1·11 <0·0001 1·07 1·16 
  Main PA 283    NS   
  PA:Ao ratio 283    NS   
Pulmonary Function Tests      
  FEV1 257 0·97 <0·0001 0·97 0·98 
  FVC  257 0·97 <0·0001 0·96 0·98 
  TLC 241 0·96 <0·0001 0·95 0·97 
  DLco 254 0·94 <0·0001 0·93 0·95 
  Kco 254 0·99   0·001 0·98 1·00 
  CPI 249 1·07 <0·0001 1·05 1·09 
Echocardiography RVSP 150 1·02 <0·0001 1·02 1·03 
GAP score 249 1.45 <0·0001 1.30 1.62 
 
Table 2. Univariate Cox regression analysis demonstrating mortality according to CALIPER 
indices (top white), visually derived HRCT indices (light grey), pulmonary function tests (dark 
grey) and echocardiography and the GAP score (bottom white). ILD=Interstitial lung disease, 
DA=decreased attenuation, TxBx=traction bronchiectasis, PA=pulmonary artery, Ao=Aorta, 
PVV=pulmonary vessel volume, FEV1=forced expiratory volume in one second, FVC=forced 
vital capacity, TLC=total lung capacity, DLco=diffusing capacity for carbon monoxide, 
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Kco=Carbon monoxide transfer coefficient, CPI=composite physiologic index, RVSP=right 
ventricular systolic pressure, NS=not significant. 
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 Hazard 
ratio 
P Value 95.0% Confidence Interval 
Lower Upper 
CALIPER analysis     
  PVV 1·53 <0·0001 1·41 1·66 
  Honeycombing  1·12   0·004 1·04 1·21 
VISUAL score analysis     
  Ground glass opacity 1·03 <0·0001 1·01 1·04 
  Reticular pattern 1·03 <0·0001 1·01 1·04 
  Honeycombing 1·04 <0·0001 1·03 1·05 
  Consolidation 1·10 <0·0001 1·06 1·15 
CALIPER PVV 1·23   0·001 1·08 1·40 
CALIPER Honeycombing  1·18   0·002 1·06 1·32 
CPI 1·05 <0·0001 1·02 1·07 
CALIPER PVV 1·39 <0·0001 1·25 1·54 
CALIPER Honeycombing  1·21   0·0004 1·09 1·34 
GAP score 1.20   0.004 1.06 1.35 
 
Table 3. Multivariate Cox regression analysis demonstrating mortality separately for 
CALIPER indices (top white), visually derived HRCT indices (light grey) and combined 
CALIPER, visually derived HRCT indices and pulmonary function tests (dark grey). The 
GAP score was substituted for CPI in the final combined multivariate model but was 
a weaker predictor of mortality than the CPI (lower white). PVV=pulmonary vessel 
volume, CPI=composite physiologic index. 
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 Hazard 
ratio 
P Value 95% Confidence Interval Harrell 
Lower Upper C Index 
GAP index staging system 2.00 <0·0001  1·61 2.48 0.62 
CALIPER-CPI  2·23 <0·0001  1·85 2·69 0.67 
CALIPER-only 2·14 <0·0001  1·78 2·58 0.67 
GAP index staging system 1·25   0·09  0.97 1.62  
CALIPER-CPI 1.99 <0·0001  1·58 2·50  
  GAP index staging system
b
    0·09 -0·03 0·48  
  CALIPER_CPI
b
    0·001  0·46 0.95  
GAP index staging system 1·41   0·0045  1·11 1·80  
CALIPER-only 1·87 <0·0001  1·51 2·30  
  GAP index staging system
b
    0·007  0·10 0·59  
  CALIPER-only
b
    0·001  0·41 0·86  
 
Table 4. Univariate Cox regression analyses (white) comparing the Gender, Age, 
Physiology (GAP) index staging system with scores derived from two separate hazard 
ratio formulae. The first formula derived from the hazard ratios of the four 
independent predictors of mortality in a combined visual, CALIPER and pulmonary 
function index multivariate model (CALIPER-CPI). The second formula derived from 
the hazard ratios of CALIPER variables that were independent predictors of mortality 
(CALIPER-only). Bivariate analyses (light and dark grey) compared the hazard ratio 
derived scores to the GAP index staging system with the results confirmed on 
bootstrapping of 1000 samples. CPI=Composite Physiologic Index, 
b
=bootstrapped 
results.  
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Figure 1. CONSORT diagram illustrating the selection of patients for the final study 
population. ILD = interstitial lung disease, CTD = connective tissue disease, IPF = 
idiopathic pulmonary fibrosis, LCH = Langerhans cell histiocytosis, LAM = 
Lymphangioleiomyomatosis, CT = computed tomography. 
 
 
Figure 2. Two examples of delineation of pulmonary arteries and veins (coloured 
red), quantified by CALIPER as a percentage of the total lung volume and expressed 
as the pulmonary vessel volume (PVV). Note that segmentation is incomplete – for 
example a left upper lobe vessel in Figure 2c (arrow). The CALIPER software also 
misclassifies small volumes of reticulation as vessels (arrowhead). 
Case 1 - A 62-year-old female ex-smoker, with a 15-pack year smoking history. Mean 
visual scores characterized the lungs as consisting of 9% total ILD extent (ground 
glass opacity=4%; reticular pattern=5%) (A). CALIPER identified a total ILD extent of 
2% of the lung (ground glass opacity=1%; reticular pattern=1%). PVV represented 2% 
of the lung volume (B).  
Case 2  - A 61-year-old female ex-smoker, with a 25-pack year smoking history. 
Visual scores characterized the lungs as consisting of 29% total ILD extent (ground 
glass opacity=3%; reticular pattern=8%; honeycombing=17%)(C). CALIPER identified 
a total ILD extent of 27% (ground glass opacity=15%; reticular pattern=11%).  PVV 
represented 6% of the lung volume (D).  
 
 
 
Figure 3. Survival curves for the IPF population in the current study. In the topmost 
graph the cases have been separated into three groups according to the Gender, 
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Age, Physiology (GAP) index staging system. Mean survival and standard errors: 
Stage 1 (n=69, blue) 50·2±3·7; Stage 2 (n=125, green) 35·5±2·6; Stage 3 (n=55, 
yellow) 19·0±1·9.  
In the middle row, stratification of patients into three groups was achieved using a 
formula derived from the hazard ratios of the three independent predictors of 
mortality in a combined visual, CALIPER and pulmonary function index multivariate 
model (CALIPER-CPI). The middle-left graph comprises three groups of equal size. 
Mean survival and standard errors: Group 1 (n=83, blue) 56·0±3·4; Group 2 (n=83, 
green) 31·9±2·7; Group 3 (n=83, yellow) 19·2±1·8. The middle-right graph consists of 
three groups each equal in size to the GAP groups. Mean survival and standard 
errors: Group 1 (n=69, blue) 56.0±3·6; Group 2 (n=125, green) 32·8±2·4; Group 3 
(n=55, yellow) 16·7±1·8.  
On the bottom row, stratification of patients into three groups was achieved using a 
formula derived from the hazard ratios of CALIPER variables that were independent 
predictors of mortality (CALIPER-only). The lower left graph comprises three groups 
of equal size. Mean survival and standard errors: Group 1 (blue) 55·4±3·3; Group 2 
(green) 30·3±2·3; Group 3 (yellow) 20·1±2·1. The lower right graph contains three 
groups equal in size to the GAP groups. Mean survival and standard errors: Group 1 
(n=69, blue) 55·5±3·6; Group 2 (n=125, green) 32·1±2·3; Group 3 (n=55, yellow) 
18·9±2·1.  
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335 Patients with IPF 
diagnosis 
51 Excluded - No 
departmental volumetric 
CT 
283 Patients with IPF  
(1CT not compatible with CALIPER) 
 
1072 Patients in 
database 
737 Patients with non-
IPF diagnosis 
115 Sarcoid 
337 Non-ILD diagnoses 
• 42 Non ILD CTD 
• 86 Infection/airways 
disease/cancer 
• 26 Non fibrotic vasculitis 
• 54 LCH, LAM, haemosiderosis 
• 129 Other non-ILD diagnosis 
1524 New ILD 
attendances 
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Two examples of delineation of pulmonary arteries and veins (coloured red), quantified by CALIPER as a 
percentage of the total lung volume and expressed as the pulmonary vessel volume (PVV). Note that 
segmentation is incomplete – for example a left upper lobe vessel in Figure 2c (arrow). The CALIPER 
software also misclassifies small volumes of reticulation as vessels (arrowhead).  
Case 1 - A 62-year-old female ex-smoker, with a 15-pack year smoking history. Mean visual scores 
characterized the lungs as consisting of 9% total ILD extent (ground glass opacity=4%; reticular 
pattern=5%) (A). CALIPER identified a total ILD extent of 2% of the lung (ground glass opacity=1%; 
reticular pattern=1%). PVV represented 2% of the lung volume (B).  
Case 2  - A 61-year-old female ex-smoker, with a 25-pack year smoking history. Visual scores characterized 
the lungs as consisting of 29% total ILD extent (ground glass opacity=3%; reticular pattern=8%; 
honeycombing=17%)(C). CALIPER identified a total ILD extent of 27% (ground glass opacity=15%; 
reticular pattern=11%).  PVV represented 6% of the lung volume (D).  
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Two examples of delineation of pulmonary arteries and veins (coloured red), quantified by CALIPER as a 
percentage of the total lung volume and expressed as the pulmonary vessel volume (PVV). Note that 
segmentation is incomplete – for example a left upper lobe vessel in Figure 2c (arrow). The CALIPER 
software also misclassifies small volumes of reticulation as vessels (arrowhead).  
Case 1 - A 62-year-old female ex-smoker, with a 15-pack year smoking history. Mean visual scores 
characterized the lungs as consisting of 9% total ILD extent (ground glass opacity=4%; reticular 
pattern=5%) (A). CALIPER identified a total ILD extent of 2% of the lung (ground glass opacity=1%; 
reticular pattern=1%). PVV represented 2% of the lung volume (B).  
Case 2  - A 61-year-old female ex-smoker, with a 25-pack year smoking history. Visual scores characterized 
the lungs as consisting of 29% total ILD extent (ground glass opacity=3%; reticular pattern=8%; 
honeycombing=17%)(C). CALIPER identified a total ILD extent of 27% (ground glass opacity=15%; 
reticular pattern=11%).  PVV represented 6% of the lung volume (D).  
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Two examples of delineation of pulmonary arteries and veins (coloured red), quantified by CALIPER as a 
percentage of the total lung volume and expressed as the pulmonary vessel volume (PVV). Note that 
segmentation is incomplete – for example a left upper lobe vessel in Figure 2c (arrow). The CALIPER 
software also misclassifies small volumes of reticulation as vessels (arrowhead).  
Case 1 - A 62-year-old female ex-smoker, with a 15-pack year smoking history. Mean visual scores 
characterized the lungs as consisting of 9% total ILD extent (ground glass opacity=4%; reticular 
pattern=5%) (A). CALIPER identified a total ILD extent of 2% of the lung (ground glass opacity=1%; 
reticular pattern=1%). PVV represented 2% of the lung volume (B).  
Case 2  - A 61-year-old female ex-smoker, with a 25-pack year smoking history. Visual scores characterized 
the lungs as consisting of 29% total ILD extent (ground glass opacity=3%; reticular pattern=8%; 
honeycombing=17%)(C). CALIPER identified a total ILD extent of 27% (ground glass opacity=15%; 
reticular pattern=11%).  PVV represented 6% of the lung volume (D).  
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Two examples of delineation of pulmonary arteries and veins (coloured red), quantified by CALIPER as a 
percentage of the total lung volume and expressed as the pulmonary vessel volume (PVV). Note that 
segmentation is incomplete – for example a left upper lobe vessel in Figure 2c (arrow). The CALIPER 
software also misclassifies small volumes of reticulation as vessels (arrowhead).  
Case 1 - A 62-year-old female ex-smoker, with a 15-pack year smoking history. Mean visual scores 
characterized the lungs as consisting of 9% total ILD extent (ground glass opacity=4%; reticular 
pattern=5%) (A). CALIPER identified a total ILD extent of 2% of the lung (ground glass opacity=1%; 
reticular pattern=1%). PVV represented 2% of the lung volume (B).  
Case 2  - A 61-year-old female ex-smoker, with a 25-pack year smoking history. Visual scores characterized 
the lungs as consisting of 29% total ILD extent (ground glass opacity=3%; reticular pattern=8%; 
honeycombing=17%)(C). CALIPER identified a total ILD extent of 27% (ground glass opacity=15%; 
reticular pattern=11%).  PVV represented 6% of the lung volume (D).  
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Survival curves for the IPF population in the current study. In the topmost graph the cases have been 
separated into three groups according to the Gender, Age, Physiology (GAP) index staging system. Mean 
survival and standard errors: Stage 1 (n=69, blue) 50·2±3·7; Stage 2 (n=125, green) 35·5±2·6; Stage 3 
(n=55, yellow) 19·0±1·9.  
In the middle row, stratification of patients into three groups was achieved using a formula derived from the 
hazard ratios of the three independent predictors of mortality in a combined visual, CALIPER and pulmonary 
function index multivariate model (CALIPER-CPI). The middle-left graph comprises three groups of equal 
size. Mean survival and standard errors: Group 1 (n=83, blue) 56·0±3·4; Group 2 (n=83, green) 31·9±2·7; 
Group 3 (n=83, yellow) 19·2±1·8. The middle-right graph consists of three groups each equal in size to the 
GAP groups. Mean survival and standard errors: Group 1 (n=69, blue) 56.0±3·6; Group 2 (n=125, green) 
32·8±2·4; Group 3 (n=55, yellow) 16·7±1·8.  
On the bottom row, stratification of patients into three groups was achieved using a formula derived from 
the hazard ratios of CALIPER variables that were independent predictors of mortality (CALIPER-only). The 
lower left graph comprises three groups of equal size. Mean survival and standard errors: Group 1 (blue) 
55·4±3·3; Group 2 (green) 30·3±2·3; Group 3 (yellow) 20·1±2·1. The lower right graph contains three 
groups equal in size to the GAP groups. Mean survival and standard errors: Group 1 (n=69, blue) 55·5±3·6; 
Group 2 (n=125, green) 32·1±2·3; Group 3 (n=55, yellow) 18·9±2·1.  
 
71x60mm (72 x 72 DPI)  
 
 
Page 39 of 75 European Respiratory Journal
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
  
 
 
Survival curves for the IPF population in the current study. In the topmost graph the cases have been 
separated into three groups according to the Gender, Age, Physiology (GAP) index staging system. Mean 
survival and standard errors: Stage 1 (n=69, blue) 50·2±3·7; Stage 2 (n=125, green) 35·5±2·6; Stage 3 
(n=55, yellow) 19·0±1·9.  
In the middle row, stratification of patients into three groups was achieved using a formula derived from the 
hazard ratios of the three independent predictors of mortality in a combined visual, CALIPER and pulmonary 
function index multivariate model (CALIPER-CPI). The middle-left graph comprises three groups of equal 
size. Mean survival and standard errors: Group 1 (n=83, blue) 56·0±3·4; Group 2 (n=83, green) 31·9±2·7; 
Group 3 (n=83, yellow) 19·2±1·8. The middle-right graph consists of three groups each equal in size to the 
GAP groups. Mean survival and standard errors: Group 1 (n=69, blue) 56.0±3·6; Group 2 (n=125, green) 
32·8±2·4; Group 3 (n=55, yellow) 16·7±1·8.  
On the bottom row, stratification of patients into three groups was achieved using a formula derived from 
the hazard ratios of CALIPER variables that were independent predictors of mortality (CALIPER-only). The 
lower left graph comprises three groups of equal size. Mean survival and standard errors: Group 1 (blue) 
55·4±3·3; Group 2 (green) 30·3±2·3; Group 3 (yellow) 20·1±2·1. The lower right graph contains three 
groups equal in size to the GAP groups. Mean survival and standard errors: Group 1 (n=69, blue) 55·5±3·6; 
Group 2 (n=125, green) 32·1±2·3; Group 3 (n=55, yellow) 18·9±2·1.  
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Survival curves for the IPF population in the current study. In the topmost graph the cases have been 
separated into three groups according to the Gender, Age, Physiology (GAP) index staging system. Mean 
survival and standard errors: Stage 1 (n=69, blue) 50·2±3·7; Stage 2 (n=125, green) 35·5±2·6; Stage 3 
(n=55, yellow) 19·0±1·9.  
In the middle row, stratification of patients into three groups was achieved using a formula derived from the 
hazard ratios of the three independent predictors of mortality in a combined visual, CALIPER and pulmonary 
function index multivariate model (CALIPER-CPI). The middle-left graph comprises three groups of equal 
size. Mean survival and standard errors: Group 1 (n=83, blue) 56·0±3·4; Group 2 (n=83, green) 31·9±2·7; 
Group 3 (n=83, yellow) 19·2±1·8. The middle-right graph consists of three groups each equal in size to the 
GAP groups. Mean survival and standard errors: Group 1 (n=69, blue) 56.0±3·6; Group 2 (n=125, green) 
32·8±2·4; Group 3 (n=55, yellow) 16·7±1·8.  
On the bottom row, stratification of patients into three groups was achieved using a formula derived from 
the hazard ratios of CALIPER variables that were independent predictors of mortality (CALIPER-only). The 
lower left graph comprises three groups of equal size. Mean survival and standard errors: Group 1 (blue) 
55·4±3·3; Group 2 (green) 30·3±2·3; Group 3 (yellow) 20·1±2·1. The lower right graph contains three 
groups equal in size to the GAP groups. Mean survival and standard errors: Group 1 (n=69, blue) 55·5±3·6; 
Group 2 (n=125, green) 32·1±2·3; Group 3 (n=55, yellow) 18·9±2·1.  
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Survival curves for the IPF population in the current study. In the topmost graph the cases have been 
separated into three groups according to the Gender, Age, Physiology (GAP) index staging system. Mean 
survival and standard errors: Stage 1 (n=69, blue) 50·2±3·7; Stage 2 (n=125, green) 35·5±2·6; Stage 3 
(n=55, yellow) 19·0±1·9.  
In the middle row, stratification of patients into three groups was achieved using a formula derived from the 
hazard ratios of the three independent predictors of mortality in a combined visual, CALIPER and pulmonary 
function index multivariate model (CALIPER-CPI). The middle-left graph comprises three groups of equal 
size. Mean survival and standard errors: Group 1 (n=83, blue) 56·0±3·4; Group 2 (n=83, green) 31·9±2·7; 
Group 3 (n=83, yellow) 19·2±1·8. The middle-right graph consists of three groups each equal in size to the 
GAP groups. Mean survival and standard errors: Group 1 (n=69, blue) 56.0±3·6; Group 2 (n=125, green) 
32·8±2·4; Group 3 (n=55, yellow) 16·7±1·8.  
On the bottom row, stratification of patients into three groups was achieved using a formula derived from 
the hazard ratios of CALIPER variables that were independent predictors of mortality (CALIPER-only). The 
lower left graph comprises three groups of equal size. Mean survival and standard errors: Group 1 (blue) 
55·4±3·3; Group 2 (green) 30·3±2·3; Group 3 (yellow) 20·1±2·1. The lower right graph contains three 
groups equal in size to the GAP groups. Mean survival and standard errors: Group 1 (n=69, blue) 55·5±3·6; 
Group 2 (n=125, green) 32·1±2·3; Group 3 (n=55, yellow) 18·9±2·1.  
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Survival curves for the IPF population in the current study. In the topmost graph the cases have been 
separated into three groups according to the Gender, Age, Physiology (GAP) index staging system. Mean 
survival and standard errors: Stage 1 (n=69, blue) 50·2±3·7; Stage 2 (n=125, green) 35·5±2·6; Stage 3 
(n=55, yellow) 19·0±1·9.  
In the middle row, stratification of patients into three groups was achieved using a formula derived from the 
hazard ratios of the three independent predictors of mortality in a combined visual, CALIPER and pulmonary 
function index multivariate model (CALIPER-CPI). The middle-left graph comprises three groups of equal 
size. Mean survival and standard errors: Group 1 (n=83, blue) 56·0±3·4; Group 2 (n=83, green) 31·9±2·7; 
Group 3 (n=83, yellow) 19·2±1·8. The middle-right graph consists of three groups each equal in size to the 
GAP groups. Mean survival and standard errors: Group 1 (n=69, blue) 56.0±3·6; Group 2 (n=125, green) 
32·8±2·4; Group 3 (n=55, yellow) 16·7±1·8.  
On the bottom row, stratification of patients into three groups was achieved using a formula derived from 
the hazard ratios of CALIPER variables that were independent predictors of mortality (CALIPER-only). The 
lower left graph comprises three groups of equal size. Mean survival and standard errors: Group 1 (blue) 
55·4±3·3; Group 2 (green) 30·3±2·3; Group 3 (yellow) 20·1±2·1. The lower right graph contains three 
groups equal in size to the GAP groups. Mean survival and standard errors: Group 1 (n=69, blue) 55·5±3·6; 
Group 2 (n=125, green) 32·1±2·3; Group 3 (n=55, yellow) 18·9±2·1.  
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Online Appendices: 
 
CT Protocols 
The CT scans were obtained using a 64-slice multiple detector CT scanner (Somatom 
Sensation 64, Siemens, Erlangen, Germany) or a 4-slice multiple detector CT scanner 
(Siemens Volume Zoom, Siemens, Erlangen, Germany. To satisfy requirements for 
processing by the CALIPER algorithm, all scans were reconstructed using a high 
spatial frequency, B70 kernel (Siemens, Munich, Germany). All patients were 
scanned from lung apices to bases, supine, at full inspiration, with 1·0mm section 
thicknesses using a peak voltage of 120kVp with tube current modulation (range 30-
140 mA). Images were viewed at window settings optimized for the assessment of 
the lung parenchyma (width 1500 H.U.; level -500 H.U.). 
 
Pulmonary function tests: 
Pulmonary function tests were analyzed if performed within 3 months of the 
corresponding CT scan according to established protocols 
31
. Spirometry (Jaeger 
Master screen PFT, Carefusion Ltd., Warwick, UK), plethysmographic lung volumes 
(Jaeger Master screen Body, Carefusion Ltd., Warwick, UK), and diffusion capacity for 
carbon monoxide (DLco) (Jaeger Master screen PFT, Carefusion Ltd., Warwick. UK) 
Parameters assessed: forced expiratory volume in one second (FEV1), forced vital 
capacity (FVC), total lung capacity (TLC), transfer coefficient of the lung for carbon 
monoxide (Kco) and single breath carbon monoxide diffusing capacity corrected for 
hemoglobin concentration (DLco). The composite physiologic index (CPI) was 
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calculated using the formula: 91·0 - (0·65 x % predicted DLco) - (0·53 x % predicted 
FVC) + (0·34 x % predicted FEV1). 
 
Echocardiography: 
A measure of pulmonary hypertension was obtained from right ventricular systolic 
pressure (RVSP) evaluated on transthoracic echocardiography, and only included if 
performed within 3 months of the CT scan. 
 
Consensus formulation for visual scores: 
The identification of systematic biases in visual scores was achieved by plotting the 
spread of differences in parenchymal pattern scores between observers. The most 
disparate 5% (two standard deviations) of values were arbitrated by a third scorer 
for all parameters except traction bronchiectasis, thereby minimizing bias within the 
original scorers. The original scorers derived a consensus for the traction 
bronchiectasis score. If a single parenchymal subtype extent was changed at 
consensus, the other parameters were modified, following CT review, to retain an 
overall sum of 100% for the four parenchymal subtypes. Similarly, if the lobar 
percentages of total interstitial disease, emphysema or mosaicism varied, the other 
two parameter extents were rescored. 
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Visual CT Variable (n = 283) 
 
 Single determination 
standard deviation 
 
CT Interstitial lung disease extent  7·24 
CT Ground glass opacity   6·15 
CT Reticular pattern   5·24 
CT Honeycombing   7·88 
CT Consolidation  2·69 
CT Total emphysema   4·99 
CT Mosaic attenuation   3·83 
CT Traction bronchiectasis severity  1·43 
 
Table 1. Single determination standard deviation values of visual CT scores for 
idiopathic pulmonary fibrosis cases. CT = computed tomography. 
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BLINDED TITLE PAGE 
Automated quantitative CT versus visual CT scoring in idiopathic 
pulmonary fibrosis: validation against pulmonary function  
 
PURPOSE: To determine whether a novel CT post-processing software technique (CALIPER) is superior 
to visual CT scoring as judged by functional correlations in idiopathic pulmonary fibrosis.  
 
MATERIALS and METHODS: 283 consecutive patients with idiopathic pulmonary fibrosis had CT 
parenchymal patterns evaluated quantitatively with CALIPER and by visual scoring. These two 
techniques were evaluated against: FEV1, FVC, DLco, Kco and a composite physiological index (CPI), 
with regard to extent of interstitial lung disease, extent of emphysema and pulmonary vascular 
abnormalities. 
 
RESULTS: CALIPER-derived estimates of interstitial lung disease extent demonstrated stronger 
univariate correlations than visual scores for most pulmonary function tests: (FEV1: CALIPER R
2
=0·29, 
visual R
2
=0·18, FVC: CALIPER R
2
=0·41, visual R
2
=0·27; DLco: CALIPER R
2
=0·31, visual R
2
=0·35; CPI: 
CALIPER R
2
=0·48, visual R
2
=0·44). Correlations between CT measures of emphysema extent and 
pulmonary function tests were weak and did not differ significantly between CALIPER and visual 
scoring. Intriguingly, the pulmonary vessel volume provided similar correlations to total interstitial 
lung disease extent scored by CALIPER for FVC, DLco and CPI (FVC: R
2
=0·45; DLco: R
2
=0·34; CPI: 
R
2
=0·53).  
 
CONCLUSIONS: CALIPER was superior to visual scoring as validated by functional correlations with 
pulmonary function tests. The pulmonary vessel volume, a novel CALIPER CT parameter with no visual 
scoring equivalent, has the potential to be a CT feature in the assessment of patients with idiopathic 
pulmonary fibrosis and requires further exploration.  
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KEY WORDS 
QUANTITATIVE COMPUTER ANALYSIS 
IDIOPATHIC PULMONARY FIBROSIS 
VISUAL CT ANALYSIS 
PULMONARY VESSEL VOLUME 
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INTRODUCTION 
Computer-based quantitative CT evaluation has the potential for greater precision than visual scoring 
in the estimation of the extent of diffuse parenchymal diseases. A new generation of computer-based 
CT software tools have demonstrated similar results between computer quantitation and visual 
quantitative scoring in small-scale studies in patients with idiopathic pulmonary fibrosis (IPF), 
1, 2
 with 
distinct improvement in performance on older, less sophisticated software programs.
3, 4
  
 
Pulmonary damage in IPF is the consequence of pathological involvement of three components of the 
lung: the parenchyma, the vasculature (largely due to pulmonary hypertension)
5
 and, in a large 
proportion of IPF patients who are cigarette smokers, co-existent emphysema.
6, 7
 Our study assessed 
baseline involvement of these three compartments using traditional visual CT evaluation and a 
sophisticated quantitative CT software tool, CALIPER (Computer-Aided Lung Informatics for Pathology 
Evaluation and Rating), developed at the (_____________). In our study, we set out to validate 
computer-based CT scoring by examining correlations between CT patterns against pulmonary 
function tests.  
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MATERIALS and METHODS  
Study population and clinical information: 
A retrospective analysis of an interstitial lung disease database identified all new consecutive 
patients, (over a four and a half year period (January 2007 to July 2011)), with a multidisciplinary 
team diagnosis of IPF according to published guidelines.
8
 Patients with a non-contrast, supine, 
volumetric thin section CT were collected, and subsequent exclusions are shown (as per CONSORT in 
Figure 1). Pulmonary function and echocardiography protocols are explained in the online appendix. 
The DICOM images for the CT scans were transferred to the (________________________________) 
for blinded CALIPER processing. Approval for this study of clinically indicated CT and pulmonary 
function data was obtained from the Institutional Ethics Committee of the (____________) and the 
Institutional Review Board of (____________).  
 
CT protocol: 
The CT scans were obtained using a 64-slice multiple detector CT scanner (Somatom Sensation 64, 
Siemens, Erlangen, Germany) or a 4-slice multiple detector CT scanner (Siemens Volume Zoom, 
Siemens, Erlangen, Germany. To satisfy requirements for processing by the CALIPER algorithm, all 
scans were reconstructed using a high spatial frequency, B70 kernel (Siemens, Munich, Germany). All 
patients were scanned from lung apices to bases, at full inspiration, using a peak voltage of 120kVp 
with tube current modulation (range 30-140 mA). Images of 1mm thickness were viewed at window 
settings optimized for the assessment of the lung parenchyma (width 1500 H.U.; level -500 H.U.). 
 
CT visual evaluation: 
Each CT scan was evaluated independently by two radiologists (___,___) with 5 and 7 years thoracic 
imaging experience respectively, blinded to all clinical information. An initial training dataset of 15 
non-study cases was used to help to identify pre-existing biases. The scores of the test cases were 
reviewed and the most widely discrepant results discussed with a third radiologist (__).  
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CTs were scored on a lobar basis using a continuous scale. The total interstitial lung disease (ILD) 
extent was estimated to the nearest 5%, and sub-classified into four patterns: reticular pattern, 
ground glass opacification, honeycombing and consolidation, using definitions from the Fleischner 
Society glossary of terms for thoracic imaging.
9
 To derive a lobar percentage for each parenchymal 
pattern, the total lobar ILD extent was multiplied by individual lobar parenchymal pattern extents and 
divided by 100. The percentage (to the nearest 5%) of each lobe that contained mosaicism (decreased 
attenuation component) or emphysema was recorded. The individual lobar percentages of each 
parenchymal pattern were summed for each radiologist and divided by six to create an averaged 
lobar score per pattern, per scorer per case.  
 
Traction bronchiectasis, as defined in the Fleischner society glossary of terms, 
9
 was assigned with a 
categorical “severity” score that took into account the average degree of airway dilatation within 
areas of fibrosis as well as the extent of dilatation throughout the lobe and was given an overall score 
of: none=0, mild=1, moderate=2, severe=3. An index of pulmonary hypertension (main pulmonary 
artery:ascending aorta ratio) was assessed by a single scorer using electronic caliper diameter 
measurements of the ascending aorta and pulmonary artery diameters at the level of the pulmonary 
artery bifurcation.
10
 
 
The identification of systematic biases in visual scores was achieved by plotting the spread of 
differences in parenchymal pattern scores between observers. The most disparate 5% (two standard 
deviations) of values were arbitrated by a third scorer for all parameters except traction 
bronchiectasis, thereby minimizing bias within the original scorers. The original scorers derived a 
consensus for the traction bronchiectasis score. If a single parenchymal subtype extent was changed 
at consensus, the other parameters were modified, following CT review, to retain an overall sum of 
100% for the four parenchymal subtypes. Similarly, if the lobar percentages of total interstitial 
disease, emphysema or mosaicism varied, the other two parameter extents were rescored. 
 
CALIPER CT evaluation: 
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Data processing: Initial data processing steps involved extraction of the lung from the surrounding 
thoracic structures and segmentation into upper, middle and lower zones. Lung segmentation was 
performed with an adaptive density-based morphological approach,
11
 whilst airway segmentation 
involved iterative three-dimensional region growing, density thresholding (thresholds including -
950HU and -960HU) and connected components analysis.  
 
Parenchymal tissue type classification was applied to 15x15x15 voxel volume units using texture 
analysis, computer vision-based image understanding of volumetric histogram signature mapping 
features and 3D morphology.
12
 The CALIPER tool was trained by sub-specialty thoracic radiologist 
consensus assessment of pathologically confirmed datasets.
2, 12
 
 
Pattern evaluation: CALIPER and visual CT were used to quantify pulmonary variables in three 
domains: 
i) total extent of interstitial disease 
ii) total extent of emphysema  
iii) pulmonary vessels 
 
CALIPER evaluation of CT data involved algorithmic identification and volumetric quantification of 
every voxel volume unit into one of eight radiological parenchymal features: normal lung, three 
grades of decreased lung attenuation (grade 1=mild, 2=moderate 3=marked), ground glass 
opacification, reticular pattern, honeycombing and the pulmonary vessels (Figure 2). Volumes for all 
eight parenchymal features were converted into a percentage using the total lung volume also 
measured by CALIPER.  
 
The final CALIPER emphysema index was defined by pre-processing the CALIPER variables against PFTs 
and visual comparison of CT scans. Using univariate linear correlations, Grade 1 decreased 
attenuation (DA) demonstrated no fit against the visual emphysema extent score or against Kco and 
was therefore not included within the CALIPER emphysema score. On inspection of colour maps, 
Grade 1 DA was shown to encompass areas of patchy centrilobular emphysema and considerable 
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amounts of normal lung (Figure 2a-c), which accounted for its large extent and lack of functional 
impact (Table 1). The sum of Grade 2 and 3 DA was taken to represent CALIPER emphysema and the 
suitability of the new variable was confirmed on analysis of individual colour maps (Figure 2a-c) that 
demonstrated that Grade 2 and 3-DA corresponded to discrete and conglomerate foci of emphysema. 
 
Segmentation of pulmonary vessels, prior to their extraction, was achieved using an optimized multi-
scale tubular structure enhancement filter based on the eigenvalues of the Hessian matrix. The filters 
calculated the 2nd-order derivatives that occurred in the regions that surrounded each pulmonary 
voxel. The eigenvalues of the Hessian matrix that were constructed from the derivatives were then 
analyzed, and from these values, it was possible to determine the likelihood that an underlying voxel 
was connected to a dense tubular structure and therefore represented a vessel.
12, 13
 The pulmonary 
vessel volume (PVV) score quantified the volumes of pulmonary arteries and veins excluding vessels 
at the lung hilum as a percentage of lung volume (Figure 3). Total ILD extent represented the sum of 
ground glass, reticular and honeycomb percentages.  
 
Statistical analysis: 
Data are given as means with standard deviations, or numbers of patients with percentages where 
appropriate. Interobserver variation for visual scores was assessed using the single determination 
standard deviation.  
 
Correlations between the extents of parenchymal patterns and individual PFTs were examined using 
Pearson’s product moment correlation. Univariate and multivariate analyses were undertaken to 
investigate relationships between CALIPER or visual CT evaluation and pulmonary function tests. In 
multivariate analyses, robustness of relationships were tested by bootstrapping the dataset with 1000 
samples. In all study analyses, a p-value of <0.01 was considered significant. Models were formally 
tested for heteroscedasticity to confirm that the assumptions of parametric analysis had been 
satisfied. Statistical analyses were performed with STATA (version 12, StatCorp, College Station, TX, 
USA).  
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RESULTS: 
Baseline data 
The final study group comprised 283 consecutive patients with a multidisciplinary diagnosis of IPF. 
Age, gender, mean visual scores, CALIPER scores and pulmonary function tests are shown in Table 1. 
Discordances between CALIPER and visual estimations of total ILD extent, emphysema and the 
various individual parenchymal patterns are shown in Table 1 and an illustrative example is shown in 
Figure 2. Visual scores identified on average 1.6 times more ILD than CALIPER and 10 times more 
honeycombing than CALIPER. Interobserver variation values for the visual scores are provided in Table 
2. 
 
Univariate relationships 
The relationships between pulmonary function parameters (FEV1, FVC, DLco, Kco, CPI) and CT 
variables are shown in Table 3. Taken across the PFTs, CALIPER ILD extent was either superior to 
(FEV1, FVC) or comparable with (DLco, CPI) visual scoring (Table 3). CALIPER ILD extent and PVV had 
very similar correlations with pulmonary function indices. The PVV correlations were either superior 
to (FEV1, FVC, CPI) or comparable with (DLco) visual ILD extent scores. PVV increased with ILD extent 
(Quadratic R
2
=0.76), but less so with more advanced disease. The visual pulmonary artery:aorta 
diameter ratio demonstrated no relationship to any functional index. 
 
Multiple regression 
Multivariate regression analyses of visual and CALIPER scores of pulmonary vasculature, total 
interstitial disease extent and emphysema extent were analysed against pulmonary function tests 
(Table 4). PVV and ILD extent could not be included in the same model due to major co-linearity and 
so were examined in separate models (Model 1 containing CALIPER ILD and Model 2 containing PVV). 
 
In Model 1, CALIPER ILD extent was clearly superior for two PFTs (FEV1, FVC), (confirmed on 
bootstrapping the dataset with 1000 samples), with visual ILD extent discarded. CALIPER and visual 
ILD extents were complementary for two PFTs (DLco, CPI) with both variables retained (again 
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confirmed on bootstrapping the dataset with 1000 samples). In the second model, CALIPER PVV was 
the strongest determinant of all examined PFTs. Although visual ILD extent was retained for DLco and 
CPI, there was minimal effect on model fit when it was discarded (DLco change: R
2
 0.04; CPI change R
2
 
0.03). Similarly, the inclusion of individual CT patterns (e.g. ground glass opacity, reticular pattern and 
honeycombing), whether quantified by CALIPER or visually, resulted in only a minimal improvement in 
correlations with PFTs (R
2
 values increasing by <0.02).  
 
Given the overall strong correlations between PVV and the various pulmonary function tests, 
relationships between PVV and RVSP were explored. Univariate analysis of a subgroup of 150 patients 
with concurrent right ventricular systolic pressure (RVSP) measured on echocardiography was 
performed. RVSP was found to explain 20% of the variability of the PVV (R
2
=0·20, P<0·0001). In the 
same 150 patients, the extent of ILD measured by both CALIPER (R
2
=0·73, P<0·0001) and visually 
(R
2
=0·47, P<0·0001), better explained PVV variability. Furthermore, with these two CT variables 
included in separate models, RVSP had no independent linkage with PVV. 
 
Post-hoc evaluation: CALIPER-based validation of CPI 
On the basis of the strong linkages between CALIPER ILD extent and PFTs, the robustness of the CPI 
was validated using CALIPER-scored ILD extent in the current study group. This showed that the same 
three best-fit PFTs, as used in the original CPI model, predicted CALIPER ILD extent: 
 
CALIPER-derived CPI = 66.0 – (0.47 x DLco) – (0.67 x FVC) + (0.32 x FEV1) 
 
Correlation of the new CPI against the old CPI score demonstrated a strong linkage as shown in the 
graph in Figure 4 (R
2
=0.95). 
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DISCUSSION 
Our study has shown that in an IPF population, CALIPER derived interstitial and vascular parameters 
correlated more strongly with pulmonary function indices (FEV1, FVC) or were at least comparable to 
visual scores (DLco, CPI). Consequently, it was felt logical to explore the robustness of the CPI using an 
objective scoring methodology (CALIPER) and, in so doing, the CPI was vindicated. Importantly, we 
have also shown that the pulmonary vessel volume, a novel CALIPER-derived percentage of the lung 
composed of pulmonary arteries and veins, is surprisingly strongly linked to the extent of interstitial 
disease.  
 
The increase in the size and number of drug trials in IPF has necessitated the development of new 
automated computer-based algorithms capable of analysing hundreds of CTs per study. The accuracy 
of the new computer-based techniques requires validation to ensure that they are at least 
comparable to visual CT scoring. One of the steps in validating the accuracy of CT in assessing disease 
extent is by examining the relationship between CT estimates, however obtained, and pulmonary 
function measures of disease severity. There are numerous structure-function studies in interstitial 
lung disease, but these have almost exclusively relied on visual scoring of total and individual pattern 
extents, with all the inherent problems of interobserver agreement.
14-16
 
 
In our study, CALIPER-derived interstitial and vascular markers clearly demonstrated stronger or 
comparable correlations with all cardinal pulmonary function tests than visual scores. The strong 
univariate correlations between both visual and CALIPER-scored total ILD extent and pulmonary 
function parameters are in line with previous IPF studies. 
16, 17
 Whilst the primary purpose of this 
study was a validation exercise of CALIPER against visual scores, the strong correlations between 
CALIPER scores and PFTs made it possible to examine historical derivation of the CPI. The CPI, 
originally derived using a subjective visual scoring system, was validated as a robust variable following 
replication of the CPI by using scores from the objective CALIPER system. 
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CALIPER was less sensitive to the extent of emphysema as compared to visual scoring and less 
accurate as judged by correlations with pulmonary function indices. Nevertheless, the positive 
correlations between visually and CALIPER scored emphysema and FVC, identified in the current 
study, are consistent with previous studies in IPF patients with co-existent emphysema. 
18, 19
 
 
On multivariate analysis of CALIPER and visual variables, it was striking that the strongest 
independent parameter predictive of pulmonary function tests was the PVV. We had assumed a priori 
that PVV was a measure of pulmonary vessel involvement, but intriguingly our investigations revealed 
that PVV was not only a ILD marker per se, but that it was co-linear with both CALIPER and visual ILD 
extents. PVV was at least as strong as CALIPER ILD extent in its linkage with key PFTs (FVC, CPI). 
Furthermore, after correcting for the extent of ILD, no linkage between PVV and RVSP remained, 
thereby establishing that PVV was not an index of pulmonary hypertension.  
 
Discordances between CALIPER and visual scores of total ILD extent and honeycombing were assessed 
by analyzing outlying cases and were found to relate largely to differences in scoring methodologies. 
On visual evaluation, each lobe represented a sixth of the total lung volume, regardless of the extent 
of lobar disease. CALIPER however, assessed parenchymal patterns, as a proportion of the total lung 
volume. Lower lobes, contracted by the retractile fibrosis of UIP, contribute a smaller percentage of 
disease than, for example, non-fibrotic upper lobes and were thus under-represented by CALIPER 
when compared to visual scores. The disparity in visual and CALIPER estimates of reticular pattern 
and ground glass opacity reflect differences in categorization of a pattern of intermixed fine 
reticulation and ground glass opacity (Figure 2d-f). Furthermore, review of individual cases showed 
that quite frequently, CALIPER characterized visually scored honeycombing as reticular pattern and 
ground glass opacity (Figure 2g-i). 
 
Our findings suggest that a computer-based quantitative CT tool such as CALIPER, has several valuable 
roles for the evaluation of patients with IPF. The improved sensitivity of CALIPER in evaluating ILD 
extent, when compared to visual scoring, has the potential to enhance understanding of the natural 
history of IPF by improving the accuracy of identifying serial change. In the sphere of drug trials, 
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computer-based CT evaluation has several possible applications. CALIPER could be used to correct for 
baseline CT disease extent in patients at the start of a trial and it could also be applied as a monitoring 
tool in the context of end-points. In the current study, recalibration of CALIPER software was required 
to analyse the Siemens B70f algorithms performed in our department, with the result that post-
recalibration, similar results for parenchymal pattern extents were achieved when CALIPER analysed 
both edge-enhancing algorithms such as a Siemens B70f and “less edge-enhancing” algorithms such 
as a Siemens B46f, (the algorithm constituting most of CALIPER’s original training dataset). A 
consequence of CALIPERs recalibration was an improvement in its versatility, which has relevance for 
multicentre drug trials, where CTs in different centres can be reconstructed with a range of different 
algorithms. 
 
CALIPER could also make a useful contribution to the investigation of combined fibrosis and 
emphysema (CPFE). The strong correlations with functional indices we have demonstrated suggest 
that CALIPER would be a more suitable tool than visual scores to quantify ILD extent in CPFE, although 
conversely visual scoring may be best placed to quantify emphysema extent. Both methodologies 
used together may better delineate the contribution of each component of CPFE.  
 
With regard to PVV, individual colour overlay maps demonstrated some contamination of the variable 
by areas of reticulation (Figure 3), particularly in cases with extensive pulmonary fibrosis. 
Nonetheless, the variable primarily reflects the quantitation, by CALIPER, of large and small vessels in 
the lung, in a way that has not, to date, been possible by human scorers. Evaluating this new 
parameter has resulted in a credible additional CT measure to visual ILD extent scores when 
quantifying interstitial involvement in IPF. A possible explanation for the relationship between PVV 
and ILD extent relates to the increased negative intra-thoracic pressure that non-compliant fibrotic 
lungs generate during inspiration. The transmission of high negative pressures into the lung 
parenchyma could in turn affect compliant vessels, resulting in vascular dilatation throughout the 
lung and an increase in capacitance. However deciphering the exact pathophysiological mechanisms 
that link interstitial damage to vascular volume requires further investigation. Furthermore, the 
potential prognostic role of PVV in patients with fibrosing lung disease is worthy of exploration. 
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Some limitations to the CALIPER technique are evident. One lies in the poor correlations we have 
identified between CALIPER emphysema extent and functional indices, (in particular Kco). Improving 
the detection of non-conglomerate emphysema by CALIPER would be a preliminary yet feasible 
objective. The complexities in scoring CT parenchymal pattern extents, be that visual or computer-
based, in a disease that is inevitably associated with volume loss are considerable. Whilst 
discrepancies between CALIPER and visual scores for parenchymal patterns such as honeycombing 
have been partly explained, further studies directed towards clarifying the reasons behind the 
differences in disease extent scores are needed. Lastly, the minor contamination of the PVV signal by 
reticulation in cases with severe fibrosis, might be considered a limitation, as it could be thought to 
dilute the relationships between PVV and functional indices. However improvement and greater 
sophistication of the algorithm to detect vessels (versus reticulation) may result in simply 
strengthening the correlations we have already shown. 
 
In conclusion, we have shown that CALIPER measures of lung disease are more strongly related to 
pulmonary function tests than visual scores. Strong links between CALIPER estimation of pulmonary 
vessel volume and pulmonary function tests suggests that evaluation of pulmonary vessel volume 
may be an important new index when assessing disease severity in patients with IPF. 
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FIGURE CAPTIONS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. CONSORT diagram illustrating the selection of patients for the final study population. ILD = 
interstitial lung disease, CTD = connective tissue disease, IPF = idiopathic pulmonary fibrosis, LCH = 
Langerhans cell histiocytosis, LAM = Lymphangioleiomyomatosis, CT = computed tomography. 
335 Patients with IPF 
diagnosis 
51 Excluded - No 
departmental volumetric 
CT 
283 Patients with IPF  
(1CT not compatible with CALIPER) 
1072 Patients in 
database 
737 Patients with non-
IPF diagnosis 
1524 New ILD 
attendances 
115 Sarcoid 
337 Non-fibrotic ILD diagnoses 
• 42 Non-fibrotic CTD 
• 86 Infection/airways disease/cancer 
• 26 Non fibrotic vasculitis 
• 54 LCH, LAM, haemosiderosis 
• 129 Other non-ILD diagnosis 
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Figure 2A-C. Axial CT slices, axial CALIPER-derived colour image overlays and three-dimensional 
CALIPER coronal rendering of the lungs displaying parenchymal patterns as various colours (Dark 
green=normal lung, light green=grade 2 decreased attenuation area, light blue=grade 2 decreased 
attenuation area, dark blue=grade 3 decreased attenuation area, yellow=ground glass opacity, 
orange=reticular pattern, brown=honeycombing).  
2A(i-iii) 75-year-old male ex-smoker with a 40-pack year smoking history. Mean visual scores of the 
CT: 7% reticular pattern, 3% honeycombing, no ground glass opacity and 24% emphysema (i). CALIPER 
characterized 5% reticular pattern, 1% honeycombing, 2% ground glass opacity, 43% Grade 1, 10% 
Grade 2 and 4% Grade 3 decreased attenuation and 3% pulmonary vessel volume (PVV). A large 
proportion of the areas with interspaced patches of centrilobular emphysema were characterized as 
Grade I decreased attenuation by CALIPER as demonstrated on overlaid axial ii) and 3D rendered 
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images (iii) but characterized as predominantly normal lung with only minor emphysema on visual 
scores.  
2B(i-iii) 48-year-old female never-smoker. Mean visual scores of the CT: 34% reticular pattern, 0.5% 
honeycombing, 45% ground glass opacity with no emphysema (i). CALIPER characterized 6% reticular 
pattern, 1% honeycombing, 62% ground glass opacity, no Grade 2 and 3 decreased attenuation and 
8% PVV. A large proportion of the areas visually labeled reticular pattern were characterized as 
ground glass opacity by CALIPER as demonstrated on overlaid axial (ii) and 3D rendered images (iii) 
reflecting a pattern of textured ground glass opacity that is often difficult to classify.  
2C(i-iii) 76-year-old male ex-smoker with a 20-pack year smoking history. Mean visual scores of the 
CT: 14% reticular pattern, 49% honeycombing, 5% ground glass opacity with no emphysema (i). 
CALIPER characterized 16% reticular pattern, 2% honeycombing, 24% ground glass opacity, 0·5% 
Grade 2 and 3 decreased attenuation and 9% PVV. A substantial proportion of the areas visually 
labeled honeycombing were characterized as reticular pattern and/or ground glass opacity by 
CALIPER as shown on overlaid axial (ii) and 3D rendered images (iii).  
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Figure 3. A 75-year-old ex-smoker diagnosed with idiopathic pulmonary fibrosis. Axial CT slice with 
CALIPER-derived colour overlay demonstrating intraparenchymal pulmonary arteries and veins (red). 
During the initial extraction process separating the lungs from the mediastinum and chest wall, the 
hilar structures including the central pulmonary arteries and veins were removed. Pulmonary vessels 
are classified by CALIPER using structure and textural analysis and computer vision-based image 
understanding of volumetric histogram signature mapping features for 9x9x9 voxel volume units. The 
pulmonary vessel volume is calculated by dividing the total lung vessel volume by the total lung 
volume and multiplying by 100. The caliber of vessels in the spared right lung are increased when 
compared to vessels within areas of fibrosis. 
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Figure 4. Graph demonstrating the relationship between CPI derived from correlations between 
pulmonary function tests and ILD extent scored visually in a separate, historic cohort of IPF patients, 
and the CPI calculated using a new formula derived from correlations between pulmonary function 
tests and ILD extent scored by CALIPER in the current cohort (R
2
=0·95).  
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Variable (n = 283 unless stated) 
Units are percentage unless stated 
 Value 
 
Median Age (years)       67 
Male/female (ratio)    219/64  
FEV1 % predicted (n=257)  70·8 ± 19·1 
FVC % predicted (n=257)  68·8 ± 20·5 
DLco % predicted (n=254)  36·1 ± 12·9 
Kco % predicted (n=254)  69·0 ± 19·2 
CPI (n=249)  55·1 ± 11·7 
Echocardiography RVSP (mmHg) (n=150)  45·1 ± 16·8 
CALIPER ILD extent   26·5 ± 18·1 
  CALIPER Ground glass opacity   17·0 ± 14·7 
  CALIPER Reticular pattern     8·5 ± 6·0 
  CALIPER Honeycombing     1·0 ± 1·7 
CALIPER Grade 1 decreased attenuation   20·8 ± 20·7 
CALIPER Grade 2 decreased attenuation    0·8 ± 2·6 
CALIPER Grade 3 decreased attenuation    0·5 ± 2·8 
CALIPER pulmonary vessel volume    5·1 ± 1·7 
Visual ILD extent  43·1 ± 17·8 
  Visual Ground glass opacity   10·4 ± 11·4 
  Visual Reticular pattern   21·7 ± 10·9 
  Visual Honeycombing     9·8 ± 12·6 
  Visual Consolidation    1·1 ± 3·3 
Visual Emphysema     4·7 ± 10·9 
Visual TxBx severity (max score 18)    7·0 ± 3·3 
Main pulmonary artery diameter (mm)  30·3 ± 4·8 
Ascending aorta diameter (mm)  34·8 ± 4·2 
 
Table 1. Patient age, gender and mean and standard deviations of pulmonary function tests, CALIPER 
and visually scored CT parameters and echocardiography data. Data represent mean values with 
standard deviations. CT = computed tomography, FEV1 = forced expiratory volume in one second, FVC 
= forced vital capacity, DLco = diffusing capacity for carbon monoxide, Kco = carbon monoxide 
transfer coefficient, TLC = total lung capacity, CPI = composite physiological index, ILD = interstitial 
lung disease, RVSP = right ventricular systolic pressure, TxBx = traction bronchiectasis. 
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Visual CT Variable (n = 283) 
 
 Single determination 
standard deviation 
CT Interstitial lung disease extent  7·24 
CT Ground glass opacity   6·15 
CT Reticular pattern   5·24 
CT Honeycombing   7·88 
CT Consolidation  2·69 
CT Total emphysema   4·99 
CT Mosaic attenuation   3·83 
CT Traction bronchiectasis severity  1·43 
 
Table 2. Single determination standard deviation values of visual CT scores for idiopathic pulmonary 
fibrosis cases. CT = computed tomography. 
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 CT Variable FEV1 FVC DLco Kco CPI  
  
ILD Visual 0.19, <0.0001  0.27, <0.0001 0.35, <0.0001 0.07, <0.0001 0.44, <0.0001 
CALIPER 0.29, <0.0001 0.41, <0.0001  0.31, <0.0001 NS 0.48, <0.0001 
Emphysema Visual NS 0.13, <0.0001 0.05, <0.0001 0.26, <0.0001 NS 
CALIPER NS 0.06, <0.0001 NS 0.08, <0.0001 0.03,   0.004 
Vessels Visual NS NS 0.03,   0.008 0.04,   0.001 NS 
 CALIPER 0.31, <0.0001 0.45, <0.0001 0.34, <0.0001 NS 0.53, <0.0001 
 
Table 3. Univariate linear regression demonstrating relationships between disease in three 
compartments characterized by visual and CALIPER-derived scores and pulmonary function tests. 
CT=Computed tomography, ILD=interstitial lung disease, FEV1=forced expiratory volume in one 
second, FVC=forced vital capacity, DLco=diffusing capacity for carbon monoxide, Kco = carbon 
monoxide transfer coefficient, CPI=composite physiological index, NS=not significant.  
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 Pulmonary 
function 
test 
CT Pattern  Beta 
Coefficient 
95% 
Confidence 
Interval 
P value Model R
2
 
Model 1 FEV1 CALIPER Emphysema -0·97 -1·49, -0·46   0·0002 0·33 
CALIPER ILD extent -0·59 -0·70, -0·48 <0·0001 
 Visual Emphysema 0.33  0.09,   0.57   0.008  
FVC CALIPER ILD extent -0·67 -0·78, -0·57 <0·0001 0·46 
 Visual Emphysema  0·40  0·23,   0·57 <0·0001 
DLco CALIPER ILD extent -0·28 -0·37, -0·18 <0·0001 0·51 
 Visual Emphysema -0·40 -0·51, -0·30 <0·0001 
 Visual ILD extent -0·28 -0·37, -0·19 <0·0001 
CPI CALIPER ILD extent  0·30  0·22,   0·39 <0·0001 0·54 
 Visual ILD extent  0·23  0·15,   0·31 <0·0001 
Model 2  FEV1 CALIPER Emphysema -0·63 -1·01, -0·25   0·001 0·34 
CALIPER PVV -6·85 -8·03, -5·66 <0·0001 
FVC CALIPER PVV -7·59 -8·72, -6·47 <0·0001 0.48 
 Visual Emphysema  0·33  0·16,   0·50   0·0001 
DLco CALIPER PVV -3·72 -4·77, -2.67 <0·0001 0·53 
 Visual Emphysema -0·44 -0·54, -0·34 <0·0001 
 Visual ILD extent -0·22 -0·31, -0·12 <0·0001 
CPI CALIPER PVV  3·80  2.91,   4·70 <0·0001 0·56 
 Visual ILD extent  0·18  0·10,   0·26 <0·0001 
 
Table 4. Multivariate linear regression demonstrating relationships significant to a level of 0·01 between 
parenchymal patterns characterized by both visual and CALIPER scores with pulmonary function tests. 
Model 1 contained CALIPER ILD extent but excluded PVV. Model 2 contained PVV but excluded CALIPER ILD 
extent. CT= Computed tomography, FEV1=forced expiratory volume in one second, FVC=forced vital 
capacity, DLco=diffusing capacity for carbon monoxide, CPI=composite physiological index, ILD=interstitial 
lung disease, PVV= pulmonary vessel volume. 
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